These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15649447)
1. Soluble Abeta oligomers ultrastructurally localize to cell processes and might be related to synaptic dysfunction in Alzheimer's disease brain. Kokubo H; Kayed R; Glabe CG; Yamaguchi H Brain Res; 2005 Jan; 1031(2):222-8. PubMed ID: 15649447 [TBL] [Abstract][Full Text] [Related]
2. Oligomeric proteins ultrastructurally localize to cell processes, especially to axon terminals with higher density, but not to lipid rafts in Tg2576 mouse brain. Kokubo H; Kayed R; Glabe CG; Saido TC; Iwata N; Helms JB; Yamaguchi H Brain Res; 2005 May; 1045(1-2):224-8. PubMed ID: 15910781 [TBL] [Abstract][Full Text] [Related]
3. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
4. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
5. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain. Ishibashi K; Tomiyama T; Nishitsuji K; Hara M; Mori H J Neurosci Res; 2006 Aug; 84(3):632-6. PubMed ID: 16721760 [TBL] [Abstract][Full Text] [Related]
6. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T; Kinoshita T; Arima K Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888 [TBL] [Abstract][Full Text] [Related]
7. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Wang J; Dickson DW; Trojanowski JQ; Lee VM Exp Neurol; 1999 Aug; 158(2):328-37. PubMed ID: 10415140 [TBL] [Abstract][Full Text] [Related]
8. Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Zhang LH; Wang X; Stoltenberg M; Danscher G; Huang L; Wang ZY Brain Res Bull; 2008 Sep; 77(1):55-60. PubMed ID: 18639746 [TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta aggregation. Finder VH; Glockshuber R Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215 [TBL] [Abstract][Full Text] [Related]
10. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes. Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243 [TBL] [Abstract][Full Text] [Related]
11. In situ Abeta pores in AD brain are cylindrical assembly of Abeta protofilaments. Inoue S Amyloid; 2008 Dec; 15(4):223-33. PubMed ID: 19065293 [TBL] [Abstract][Full Text] [Related]
12. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Gouras GK; Almeida CG; Takahashi RH Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263 [TBL] [Abstract][Full Text] [Related]
13. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease. Montalto MC; Farrar G; Hehir CT Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026 [TBL] [Abstract][Full Text] [Related]
14. Part of membrane-bound Abeta exists in rafts within senile plaques in Tg2576 mouse brain. Kokubo H; Saido TC; Iwata N; Helms JB; Shinohara R; Yamaguchi H Neurobiol Aging; 2005 Apr; 26(4):409-18. PubMed ID: 15653169 [TBL] [Abstract][Full Text] [Related]
16. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template. Ha C; Park CB Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
18. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064 [TBL] [Abstract][Full Text] [Related]
19. Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Rowan MJ; Klyubin I; Wang Q; Anwyl R Biochem Soc Trans; 2005 Aug; 33(Pt 4):563-7. PubMed ID: 16042545 [TBL] [Abstract][Full Text] [Related]
20. Blood-borne factors inhibit Alzheimer's beta-amyloid fibril formation in vitro. Ono K; Noguchi-Shinohara M; Samuraki M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M Exp Neurol; 2006 Nov; 202(1):125-32. PubMed ID: 16806179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]